Optimal Dexmedetomidine Dose to Prevent Emergence Agitation Under Sevoflurane and Remifentanil Anesthesia During Pediatric Tonsillectomy and Adenoidectomy
Autor: | Xiao-guang Cui, Yan-zhuo Zhang, Chun-yu Song, Jia-min Wu, Xue Wang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
medicine.medical_treatment Remifentanil sevoflurane Sevoflurane 03 medical and health sciences adenoidectomy 0302 clinical medicine Adenoidectomy medicine Pharmacology (medical) Dexmedetomidine tonsillectomy Original Research Pharmacology business.industry lcsh:RM1-950 dexmedetomidine medicine.disease emergence agitation Tonsillectomy 030104 developmental biology lcsh:Therapeutics. Pharmacology Emergence delirium 030220 oncology & carcinogenesis Anesthesia FLACC scale Tonsillectomy with Adenoidectomy business medicine.drug remifentanil |
Zdroj: | Frontiers in Pharmacology, Vol 10 (2019) Frontiers in Pharmacology |
ISSN: | 1663-9812 |
DOI: | 10.3389/fphar.2019.01091/full |
Popis: | Background: Emergence agitation (EA) is a common pediatric complication after sevoflurane anesthesia that can be prevented with dexmedetomidine. However, an inappropriate dose of dexmedetomidine can cause prolonged sedation and cardiovascular complications. Thus, we evaluated the optimal dose (ED95) of dexmedetomidine for preventing EA with sevoflurane and remifentanil anesthesia after pediatric tonsillectomy and adenoidectomy. Methods: We enrolled American Society of Anesthesiologists (ASA) I and II children 3–7 years of age who underwent tonsillectomy with adenoidectomy. During induction, dexmedetomidine was infused for 10 min. Anesthesia was induced with sevoflurane and maintained with sevoflurane and remifentanil, resulting in a bispectral spectrum index (BIS) range from 40 to 60. Extubation time, surgical and anesthetic duration time, and duration time in the postanesthesia care unit (PACU) stay were recorded. EA [measured with Pediatric Anaesthesia Emergence Delirium (PAED) scores] and pain [measured with Face, Legs, Activity, Cry, Consolability (FLACC) scores] were assessed at extubation (E0), 15 min after extubation (E1), and 30 min after extubation (E2). If EA occurred, the next surgical procedure included increased dexmedetomidine by 0.1 μg/kg, and if not, the drug was reduced by 0.1 μg/kg. Results: The 50% effective dose (ED50) of dexmedetomidine for preventing EA after sevoflurane and remifentanil anesthesia for tonsillectomy and adenoidectomy was 0.13 μg/kg, and its 95% confidence interval is 0.09–0.19 μg/kg; ED95 was 0.30 μg/kg, and its 95% confidence interval is 0.21–1.00 μg/kg. Conclusion: Intravenous dexmedetomidine infusion at ED50 (0.13 μg/kg) or ED95 (0.30 μg/kg) during induction for 10 min can prevent half or almost all EA after sevoflurane and remifentanil anesthesia during pediatric tonsillectomy and adenoidectomy. |
Databáze: | OpenAIRE |
Externí odkaz: |